Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma

By sjmartinez • September 15, 2024

Klingbeil KD, Wilde BR, Graham DS, Lofftus S, McCaw T, Matulionis N, Dry SM, Crompton JG, Eilber FC, Graeber TG, Shackelford DB, Christofk HR, Kadera BE. Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma. Cancers (Basel). 2024 Aug 30;16(17):3031. doi: 10.3390/cancers16173031. PMID: 39272889; PMCID: PMC11394161.

Tags: Asparaginase, asparagine metabolism, ATF4, complex I inhibitor, electron transport chain, mTORC1 signaling, patient-derived organoids, patient-derived xenograft, Publications, Pulmonary, Critical Care & Sleep Medicine, well-differentiated/dedifferentiated liposarcoma

Clinical phenotypes in acute and chronic infarction explained through human ventricular electromechanical modelling and simulations

Zhou X, Wang ZJ, Camps J, Tomek J, Santiago A, Quintanas A, Vazquez M, Vaseghi M, Rodriguez B. Clinical phenotypes in acute and chronic infarction[...]

Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

Nguyen T, Koric A, Chang CE, Barul C, Radoi L, Serraino D, Purdue MP, Kelsey KT, McClean MD, Negri E, Edefonti V, Moysich K, Zhang[...]

Expert Perspective: Management of Relapses in Giant Cell Arteritis

Alba MA, Unizony S, Warrington KJ, Murgia G, Prieto-González S, Salvarani C, Matteson EL, Kermani TA. Expert Perspective: Management of Relapses in Giant Cell Arteritis.[...]